ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Affymax, Inc. 

4001 Miranda Avenue

Palo Alto  California  94304  U.S.A.
Phone: 650-812-8700 Fax: 650-424-0832


SEARCH JOBS




Collaborations

Mosaic Technologies 





 Company News
Affymax, Inc. (AFFY) Announces Update on Listing, Senior Leadership and Board Changes 6/7/2013 10:28:12 AM    More...
Affymax, Inc. (AFFY) CEO Steps Down as Restructuring Firm Steps in 5/15/2013 8:57:51 AM    More...
Affymax, Inc. (AFFY) Reports Fourth Quarter and Year-End 2012 Financial Results 4/2/2013 6:30:17 AM    More...
Affymax, Inc. (AFFY) May File for Bankruptcy; Cuts 75 Pct of Workforce 3/19/2013 7:18:09 AM    More...
Affymax, Inc. (AFFY) to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/7/2013 6:17:14 AM    More...
The New England Journal of Medicine Publishes Pivotal Trial Data for Affymax, Inc. (AFFY), and Takeda Pharmaceuticals's OMONTYS® (peginesatide) Injection for Treatment of Anemia in Adult Chronic Kidney Disease Patients on Hemodialysis 1/24/2013 9:01:03 AM    More...
Takeda Pharmaceutical Co. Ltd. (TKPYY) and Affymax, Inc. (AFFY) Announce Supply Agreement for OMONTYS® (Peginesatide) Injection With DSI Renal, Inc. 1/7/2013 10:07:12 AM    More...
Affymax, Inc. (AFFY) to Present at the J.P. Morgan Healthcare Conference 1/4/2013 6:13:20 AM    More...
Affymax, Inc. (AFFY) and Takeda Pharmaceuticals Announce Permanent J-Code for OMONTYS® (peginesatide) Injection is in Effect 1/3/2013 9:49:13 AM    More...
Affymax, Inc. (AFFY) to Present at the Lazard Capital Markets Healthcare Conference 11/12/2012 9:10:40 AM    More...
12345678910...